Knome’s New CEO Signals New Directions in Genome Interpretation

11 Jan 2012 by Jonas Lee

Bio IT World’s Kevin Davies covers Knome’s announcement of its new CEO and discussion of 2012 direction. Full article.

Knome’s Genome Interpretation Technology Accelerates Discovery of New Parkinson’s Disease Biomarker New Research Revealing VPS35 Mutation in Parkinson’s Disease Published in...
Cancer Background Cancers ultimately trace to changes in the genome that...
kGAP Interpretation Engine ...
Genome Reference Pool ...
The best in personalized medicine? Complete Genomics and Knome Prof. Kenny Beckman, the director of the Biomedical Genomics Center...

affiliates

who we are

Knome sequences and interprets whole genomes.

connect with us

address

25 First Street, Suite 107
Cambridge, MA 02141

telephone

(617) 941-4130

Knome does not provide medical advice, diagnosis or treatment. Analyses and reports provided by Knome are for informational purposes only and are subject to change. You should consult your physician if you have questions regarding any medical condition, before starting any new treatment, and before stopping any treatment that has been prescribed for you. When applicable, Knome performs its sequencing services in a CLIA-certified laboratory. The results and analysis presented have not been cleared or approved by the FDA or similar government institutions.

Blog

affiliates

who we are

connect with us

address

telephone

general email

researcher services

jobs

press